Ildong Holdings Co., Ltd. (000230.KS)

KRW 6600.0

(-5.44%)

Total Liabilities Summary of Ildong Holdings Co., Ltd.

  • Ildong Holdings Co., Ltd.'s latest annual total liabilities in 2023 was 707.09 Billion KRW , up 1.97% from previous year.
  • Ildong Holdings Co., Ltd.'s latest quarterly total liabilities in 2024 Q1 was 695.49 Billion KRW , down -1.64% from previous quarter.
  • Ildong Holdings Co., Ltd. reported annual total liabilities of 693.45 Billion KRW in 2022, down -5.96% from previous year.
  • Ildong Holdings Co., Ltd. reported annual total liabilities of 737.42 Billion KRW in 2021, up 49.34% from previous year.
  • Ildong Holdings Co., Ltd. reported quarterly total liabilities of 691.61 Billion KRW for 2024 Q2, down -0.56% from previous quarter.
  • Ildong Holdings Co., Ltd. reported quarterly total liabilities of 707.09 Billion KRW for 2023 Q4, up 3.13% from previous quarter.

Annual Total Liabilities Chart of Ildong Holdings Co., Ltd. (2023 - 2006)

Historical Annual Total Liabilities of Ildong Holdings Co., Ltd. (2023 - 2006)

Year Total Liabilities Total Liabilities Growth
2023 707.09 Billion KRW 1.97%
2022 693.45 Billion KRW -5.96%
2021 737.42 Billion KRW 49.34%
2020 493.78 Billion KRW 1.91%
2019 484.53 Billion KRW 382.01%
2018 100.52 Billion KRW 0.32%
2017 100.2 Billion KRW 3.04%
2016 97.24 Billion KRW -72.66%
2015 355.65 Billion KRW 23.75%
2014 287.39 Billion KRW -4.71%
2013 301.6 Billion KRW 38.8%
2012 217.29 Billion KRW 7.85%
2011 201.48 Billion KRW -14.71%
2010 236.23 Billion KRW 9.74%
2009 215.26 Billion KRW 8.76%
2008 197.92 Billion KRW 41.1%
2007 140.27 Billion KRW 26.62%
2006 110.78 Billion KRW 0.0%

Peer Total Liabilities Comparison of Ildong Holdings Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Yuyu Pharma, Inc. 77.85 Billion KRW -808.19%
Dong-A Socio Holdings Co., Ltd. 929.79 Billion KRW 23.951%
HANDOK Inc. 449.7 Billion KRW -57.235%
Kukje Pharma Co., Ltd. 85.67 Billion KRW -725.37%
Yuhan Corporation 712.33 Billion KRW 0.736%
Dong-A ST Co., Ltd. 631.91 Billion KRW -11.898%
SAMSUNG PHARM. Co., LTD. 15.89 Billion KRW -4348.695%
Hanmi Pharm. Co., Ltd. 851.82 Billion KRW 16.99%
Hanall Biopharma Co.,Ltd 53.52 Billion KRW -1220.97%
Ilyang Pharmaceutical Co.,Ltd 205.87 Billion KRW -243.459%
Dong Sung Bio Pharm.Co.,Ltd. 75.17 Billion KRW -840.652%
MYUNGMOON Pharm co.,Ltd 147.79 Billion KRW -378.433%
Hana Pharm Co., Ltd. 70.4 Billion KRW -904.381%
Yuyu Pharma, Inc. 77.85 Billion KRW -808.19%
Ilsung Pharmaceuticals Co., Ltd. 36.43 Billion KRW -1840.642%
REYON Pharmaceutical Co., Ltd. 251.15 Billion KRW -181.543%
Aprogen pharmaceuticals,Inc. 220.7 Billion KRW -220.381%
JW Holdings Corporation 827.51 Billion KRW 14.551%
Ildong Pharmaceutical Co., Ltd. 436.99 Billion KRW -61.809%
Chong Kun Dang Pharmaceutical Corp. 586.79 Billion KRW -20.502%
JW Pharmaceutical Corporation 379.59 Billion KRW -86.275%
Shin Poong Pharm.Co.,Ltd. 79.3 Billion KRW -791.657%
Hyundai Pharmaceutical Co., Ltd. 69.96 Billion KRW -910.606%
Samil Pharmaceutical Co.,Ltd 242.85 Billion KRW -191.163%
Jeil Pharmaceutical Co.,Ltd 330.29 Billion KRW -114.081%
Yuyu Pharma, Inc. 77.85 Billion KRW -808.19%
Kwang Dong Pharmaceutical Co., Ltd. 490.01 Billion KRW -44.3%
Daewoong pharmaceutical Co.,Ltd 858.02 Billion KRW 17.591%
JW Pharmaceutical Corporation 379.59 Billion KRW -86.275%
Yuhan Corporation 712.33 Billion KRW 0.736%
Jeil Pharma Holdings Inc 477.81 Billion KRW -47.987%
Yungjin Pharm. Co., Ltd. 136.96 Billion KRW -416.248%
Suheung Co., Ltd. 516.66 Billion KRW -36.857%
JW Pharmaceutical Corporation 379.59 Billion KRW -86.275%
Samjin Pharmaceuticals Co., Ltd. 154.53 Billion KRW -357.561%
Korea United Pharm Inc. 89.96 Billion KRW -685.966%
CKD Bio Corp. 170.76 Billion KRW -314.087%
Daewon Pharmaceutical Co., Ltd. 243.73 Billion KRW -190.11%
Dongwha Pharm.Co.,Ltd 157.65 Billion KRW -348.504%
Whan In Pharm Co.,Ltd. 43.01 Billion KRW -1543.68%
Shin Poong Pharm.Co.,Ltd. 79.3 Billion KRW -791.657%
Chong Kun Dang Holdings Corp. 632.51 Billion KRW -11.791%
Boryung Corporation 373.1 Billion KRW -89.515%
Bukwang Pharmaceutical Co., Ltd. 208.19 Billion KRW -239.628%
Ilyang Pharmaceutical Co.,Ltd 205.87 Billion KRW -243.459%
JW Lifescience Corporation 96.44 Billion KRW -633.174%